Worth reading
70In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
Acquisition of shares in 有限会社板倉歯科器材店 (making it a subsidiary)Disclosing companyMedical Net,Inc.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Execution Date / Effective Date16 October 2026 (completed)
Target company
Wholesale of dental medical supplies and dental equipment and materials
Location Naha, Okinawa PrefectureShare capital ¥6 millionDate of incorporation 11 June 1975
Procedures and assumptions
Management structure after acquisitionOKAMURA CORPORATION holds 100.0%. The representative director is Itakura Jun (板倉潤). Employee treatment: not disclosed.
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares in 有限会社板倉歯科器材店 (making it a subsidiary) |
| Name of the Subject Company | 有限会社板倉歯科器材店 |
| Business Description of the Subject Company | Wholesale of dental medical supplies and dental equipment and materials |
| Location of the Subject Company | Naha, Okinawa Prefecture |
| Capital Stock of the Subject Company | ¥6 million |
| Date of Establishment of the Subject Company | 11 June 1975 |
| Voting rights ownership percentage | After 100.0％ (before not disclosed) |
| Execution Date / Effective Date | 16 October 2026 (completed) |
| Management structure after acquisition | OKAMURA CORPORATION holds 100.0%. The representative director is Itakura Jun (板倉潤). Employee treatment: not disclosed. |
Items this document does not state (23)
Counterparty nameNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The acquisition of shares announced in the disclosure dated 28 September 2026 was completed as of today.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.